VAXZEVRIA Japan Post-Marketing Surveillance (PMS) for the Long-term Safety of VAXZEVRIA

Clinical trial NCT05135455 · COMPLETED

Trial details

NCT number: NCT05135455
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Prevention of Infectious Disease Caused by SARS-CoV-2

Start date: 2022-04-21
Primary completion: 2023-08-31
Enrollment: 467

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.